Gibler Appointed President & CEO of UC Health University Hospital
CINCINNATIW. Brian Gibler, MD, has been appointed president and chief executive officer of UC Health University Hospital and senior vice president of UC Health effective Oct. 1.
Gibler has served since 1995 as the Richard C. Levy Professor and chair of emergency medicine at the University of Cincinnati College of Medicine. Gibler also is the medical director of emergency services at University Hospital. He will step down as chair of emergency medicine when he assumes his new position at University Hospital.
A graduate of the UC Emergency Medicine Residency Training Program where he served as chief resident his senior year, Gibler joined the UC faculty in 1989 after coming from Vanderbilt University School of Medicine in Nashville.
Gibler founded the Heart ER Program at University Hospital and served as the director from 1991 through 1997. He also was the executive co-chairman of CRUSADE, a national quality improvement initiative to develop hospital-based strategies to reduce instances of myocardial infarction. Gibler also is an editor and referee for numerous emergency medicine and cardiology journals.
"Dr. Gibler is a highly effective leader and an accomplished emergency medicine physician who has both deep roots in our community and at University Hospital. His training, experience and passion for University Hospital make him the ideal chief executive, said James Kingsbury, president and CEO of UC Health. "Dr. Gibler is the right person to lead the hospital, especially as we become UC Health.
UC Health is an affiliate of the University of Cincinnati and includes University of Cincinnati Physiciansthe faculty practice of the UC College of Medicineand University and West Chester hospitals. With over 9,500 health care professionals and 652 physicians, it represents the largest group of specialty physicians in Greater Cincinnati.
UC Health University Hospital President and CEO W. Brian Gibler
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.